Abstract
Because of its potential as a low cost first-line monotherapy for the most common vulvovaginal infections, we evaluated fenticonazole nitrate in a prospective, open-label, multicenter pilot study with 101 sexually active women (per-protocol; 16 to 61 years of age) with vulvovaginitis involving single or mixed infections with Candida albicans, Trichomonas vaginalis, and/or Gardnerella vaginalis. Fenticonazole nitrate (1 g) was administered as vaginal ovules, once daily on days 1 and 3. Eradication (direct phase-contrast microscopy of vaginal swabs and/or microbiological culture) on day 8 was 90% (C. albicans, 26/29, p < 0.001), 70% (T. vaginalis, 7/10, p = 0.161), 67% (G. vaginalis, 22/33, p < 0.009), and 45% (mixed infection, 13/29, p = 0.001). After 28 days, relapse was 0% for candidiasis and trichomoniasis, 27% (6/22) for G. vaginalis, and 23% (3/13) for mixed infection. Overall, eradication of all offending pathogens was achieved in 67% of the total per-protocol population, with a relapse rate of only 16%. Score sums for symptoms improved from 7.0 (baseline) to 1.7 (day 8), and 0.71 (day 28), (p < 0.001). Treatment was safe and well tolerated. The results of our pilot study suggest that application of fenticonazole nitrate 1...Continue Reading
References
Sep 1, 1979·Postgraduate Medical Journal·R Hurley, J De Louvois
Jul 1, 1992·International Journal of STD & AIDS·P G Larsson
Feb 1, 1991·Journal of Clinical Microbiology·R P NugentS L Hillier
Feb 1, 1991·Journal of Chemotherapy·A NovelliP Periti
Jan 1, 1990·Sexually Transmitted Diseases·V Redondo-LopezJ D Sobel
Sep 1, 1990·Archives of Internal Medicine·V M SchaafK Borchardt
Jun 1, 1989·Antimicrobial Agents and Chemotherapy·B M JonesB I Duerden
Mar 1, 1996·Epidemiology·A M Geiger, B Foxman
Dec 20, 1997·The New England Journal of Medicine·J D Sobel
Mar 25, 1998·The Journal of Antimicrobial Chemotherapy·P E Hay
Jun 20, 1998·Clinical Microbiology Reviews·D PetrinG Garber
Jun 5, 1998·Journal of General Internal Medicine·P L CarrR H Friedman
Jun 17, 1999·Clinical Obstetrics and Gynecology·H K Haefner
Jul 2, 1999·Antimicrobial Agents and Chemotherapy·J Samuelson
Jul 11, 2000·São Paulo Medical Journal = Revista Paulista De Medicina·E F MurtaS J Adad
Aug 10, 2001·Infectious Diseases in Obstetrics and Gynecology·J BornsteinH Abramovici
Feb 28, 2002·Obstetrics and Gynecology·Daron G FerrisMark S Litaker
Aug 2, 2002·Expert Opinion on Pharmacotherapy·Jack D Sobel
Citations
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Stavroula AntonopoulouAristea Velegraki
Sep 30, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G DondersD Janssens
Oct 9, 2008·Drugs·Stefano Veraldi, Rodolfo Milani
Apr 18, 2009·Current Opinion in HIV and AIDS·Joseph RomanoPaulina E Kaptur
Sep 15, 2010·PloS One·Christopher O CiccolellaRobert A Ludwig
Dec 18, 2019·Future Microbiology·Fabio TumiettoMaurizio Sanguinetti
Aug 31, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Lei MaWei Yi